TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 2 | 1 | 4 | -0 | 1 | 14 | 26 | 15 | 19 | 12 |
P | %wins | 75 | 25 | 75 | 75 | 25 | 33 | 51 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/1/22 21:32 | 5/31/22 | MIST | Milestone Pharmaceuticals Inc. | A8 | Health | Drug | Pharmaceutical Preparations | Truex Paul F | A8 | D | P.d | 28 | 5.60 | 0 | 5 | 7 | 82 | D | |||||||||||||||
9/7/17 18:56 | 9/7/17 | ANTH | Anthera Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Truex Paul F | CA | D | P | 7 | 1.34 | 0 | 5 | 42 | 17 | I | |||||||||||||||
7/2/12 15:53 | 6/29/12 | ANTH | Anthera Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Truex Paul F | CA | DO | P,CEO | P | 15 | 0.7600 | 0 | 20 | 3 | 725 | I | -87 | -92 | -88 | -69 | -65 | -69 | -73 | -77 | 3 | 15 | 57 | 46 | -3 | -26 |
8/31/11 20:02 | 8/29/11 | TSRX | Trius Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Truex Paul F | CA | D | P | 14 | 6.80 | 0 | 2 | 18 | 13 | D | 67 | 0 | -16 | -14 | 4 | 2 | 4 | -4 | -3 | 0 | 16 | -21 | |||
11/24/10 12:36 | 11/23/10 | TSRX | Trius Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Truex Paul F | CA | D | P.d | 4 | 3.50 | 0 | 1 | 10 | 11 | D | -14 | -12 | 0 | 8 | 6 | 0 | -8 | 3 | 59 | 131 | 106 | ||||
3/2/10 21:07 | 3/1/10 | ANTH | Anthera Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Truex Paul F | CA | DO | P,CEO | P | 7 | 7.12 | 1 | 1 | 0 | 664 | D | 0 | -2 | -4 | -17 | -46 | -24 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |